Trump scolds phar­ma ex­ecs, de­mand­ing low­er prices, more US man­u­fac­tur­ing while promis­ing to slash FDA regs

Some of the top CEOs of the phar­ma in­dus­try got to­geth­er with Pres­i­dent Trump Tues­day morn­ing look­ing for com­mon ground. In­stead, they got an­oth­er lec­ture on drug pric­ing, a re­newed promise that the FDA will speed up new drug ap­provals with just a frac­tion of the old reg­u­la­tions in play, and as­sur­ances of an FDA pick wait­ing in the wings who will help put every­thing in or­der.

“We have to get the prices way down,” said Trump, flanked by Cel­gene CEO Bob Hug­in and Mer­ck CEO Ken Fra­zier. “The pric­ing has been as­tro­nom­i­cal for our coun­try.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER